XML 29 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Changes in Shareholders’ Equity/(Deficit) - USD ($)
Number of shares
Share capital
Warrants Reserve
Reserves
Accumulated Deficit
Total
Balance at Mar. 31, 2022   $ 4,537,055 $ 255,188 $ (3,093,543) $ 1,698,700
Balance (in Shares) at Mar. 31, 2022          
Psyence Group Inc contribution   1,397,086 1,397,086
Net profit (loss) for the year   (3,206,403) (3,206,403)
Other comprehensive income (loss)   (89,828) (89,828)
Balance at Mar. 31, 2023   5,934,141 165,360 (6,299,946) (200,445)
Balance (in Shares) at Mar. 31, 2023          
Issuance of shares to Psyence Group Inc  
Issuance of shares to Psyence Group Inc (in Shares) 8,365          
Issuance of shares to NCAC shareholders   37,336,416 37,336,416
Issuance of shares to NCAC shareholders (in Shares) 13,040          
Issuance of shares for debt settlement   718,500 718,500
Issuance of shares for debt settlement (in Shares) 251          
Issuance of shares to third party advisors   2,136,340 2,136,340
Issuance of shares to third party advisors (in Shares) 746          
Net profit (loss) for the year   (51,159,048) (51,159,048)
Other comprehensive income (loss)   195,697 195,697
Balance at Mar. 31, 2024   46,125,397 361,057 (57,458,994) (10,972,540)
Balance (in Shares) at Mar. 31, 2024 22,402          
Issuance of shares to third party advisors   $ 241,379 241,379
Issuance of shares to third party advisors (in Shares) 586 586        
Issuance of shares for convertible note   $ 4,617,286 4,617,286
Issuance of shares for convertible note (in Shares) 38,156 38,156        
Issuance of warrants   682,482 682,482
Issuance of shares for ELOC, net of issuance costs   6,410,395 6,410,395
Issuance of shares for ELOC, net of issuance costs (in Shares) 222,292          
Issuance of shares for warrant exchange   $ 192,060 192,060
Issuance of shares for warrant exchange (in Shares) 1,104 1,104        
Issuance of shares for promissory notes   $ 2,084,927 2,084,927
Issuance of shares for promissory notes (in Shares) 99,540          
Issuance of shares for Psyence Labs Ltd shares   $ 722,033 722,033
Issuance of shares for Psyence Labs Ltd shares (in Shares) 35,594 35,594        
Issuance of units for PIPE financing, net of issuance costs   $ 273,179 1,468,872 1,742,051
Issuance of units for PIPE financing, net of issuance costs (in Shares) 47,679 47,679        
Issuance of shares for warrant conversion   $ 1,085,649 (1,085,649)
Issuance of shares for warrant conversion (in Shares) 100,668          
Net profit (loss) for the year   1,011,790 1,011,790
Other comprehensive income (loss)   (9,859) (9,859)
Balance at Mar. 31, 2025   $ 61,752,305 $ 1,065,705 $ 351,198 $ (56,447,204) $ 6,722,004
Balance (in Shares) at Mar. 31, 2025 568,021